Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

September 10, 2015

Newsletter Sponsor

Taking You Further. Clinical Phase I–IIa Capability.
From MPI Research
MPI Research is renowned in early-stage development for deep scientific expertise and state-of-the-art technology at the world’s largest preclinical research facility. With our acquisition of The Jasper Clinic — a 50-bed clinical trial unit with a long track record in first-in-human studies — we have taken a further significant step towards being the leading integrated resource for early development. We now offer you the full continuum of lead to proof-of-concept services for new drug candidates.

	Industry News

SGS Life Science Services Announces Biosafety Level 2 Compliance at Fairfield, NJ, Facility For Both Analytical and Microbiological Testing

FDA Expands Warning on Becton-Dickinson Syringes Being Used to Store Compounded or Repackaged Drug

goBalto Joins Society for Clinical Research Sites as Global Impact Partner

Ontario Government, University of Toronto, and MaRS secure Johnson & Johnson Innovation, JLABS for Toronto

USP Names Senior VP of Global External Affairs

Valeant And Progenics Announce FDA Acceptance Of NDA Submission For Oral RELISTOR

	Featured Articles

CMOs and GDUFA: Shaping a New World CMOs and GDUFA: Shaping a New World In July 2012, the U.S. Congress enacted the Food and Drug Administration Safety and Innovation Act (FDASIA), which contained the Generic Drug User Fee Amendments (GDUFA). GDUFA has noble goals in its ... read more »

FDA Delays Critical Decision on Generic Drug Labeling and Scope of Potential Tort Liability Regulations FDA Delays Critical Decision on Generic Drug Labeling The current regulations of the Food and Drug Administration (FDA) impose different requirements upon brand-name and generic drug manufacturers when it comes to changes in labeling to reflect newly ... read more »

	Featured Partners

UPM Pharmaceuticals: Formulating your future
From UPM
Find out more on our large-scale manufacturing capabilities for tablets, capsules and semi-solid dosage forms. read more »

One 2 One, a Service of Hospira
Expansive Global Manufacturing
Be at home with broad-scale development services and global contract manufacturing. Be wherever your sterile injectable product needs to be. read more »

	Featured Announcements

Top 15 Trends in Biopharmaceutical Manufacturing, 2015 Top 15 Trends in Biopharmaceutical Manufacturing, 2015 BioPlan Associates’ 12th Annual Report and Survey of BioManufacturing, the industry's definitive, ... read more »

	Featured Video

Interview with Merge eClinical at DIA 2015
Interview with Merge eClinical at DIA 2015
In this video, Mike Auerbach speaks with Zaher El-Assi, President of Merge eClinical, about why the eClinicalOS electronic data capture system offers the best support possible for clinical studies. ... read more »

INC Research: Committed to Site and Patient Access
INC Research: Committed to Site and Patient Access
Clare Grace, Ph.D., Vice President of Site and Patient Access at INC Research, talks with Mike Auerbach of Pharmaceutical Outsourcing at DIA 2015 about building relationships with clinical trial sites... read more »

	Featured Whitepaper

Application of SoloVPE to UV Concentration Measurement Application of SoloVPE to UV Concentration Measurement FUJIFILM Diosynth Biotechnologies is implementing the newest evolution of UV-Vis spectroscopy. The simple-touse SoloVPE System provides accurate ... read more »

	Events


ChemOutsourcing		CE Pharm 2015

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA